Department of Physical Therapy at the Children's Hospital of Colorado, Aurora, USA.
Department of Biostatistics and Informatics, University of Colorado School of Public Health, Aurora, Colorado, USA.
Pediatr Pulmonol. 2024 Oct;59(10):2597-2605. doi: 10.1002/ppul.27073. Epub 2024 May 23.
Limited data exist on the gross motor abilities of children with cystic fibrosis (CF). The objective of this research project was to implement a systematic gross motor assessment in children with CF ages 4-12 years. Secondarily, we aimed to assess demographic characteristics associated with gross motor delays.
Physical therapists aimed to evaluate at least 50% of eligible children (4-12 years) at our CF Center over 1 year using the Bruininks-Oseretsky Test of motor Proficiency, second edition (BOT-2). Delays are defined by scores less than 18th percentile. Demographic and clinical data included body mass index, hospitalizations, genotype, and comorbidities. Basic descriptive statistics summarized patient information. Parametric and nonparametric methods compared groups of interest. Linear regression assessed associations between BOT-2 measures and clinical characteristics.
The BOT-2 evaluation was successfully implemented with 69% of eligible patients being evaluated. Forty-five (62.5%) scored below average. Impaired strength (22.2%) was most common, followed by impaired balance (16.7%), running speed and agility (15.3%), and bilateral coordination (8.3%). 15.5% scored below average on their total motor composite score (TMC). Increased age, comorbidities and hospitalizations were associated with a lower TMC.
The BOT-2 was successfully implemented as part of routine CF care to screen for gross motor delays in children. Results suggest that a high percentage of children with CF, especially older children with comorbid conditions or a history of hospitalization, have impaired gross motor function. These findings support the need for routine gross motor evaluations and physical therapy interventions within pediatric CF clinics.
囊性纤维化(CF)患儿的总体运动能力相关数据有限。本研究项目的目的是对 4-12 岁 CF 患儿实施系统的总体运动评估。其次,我们旨在评估与总体运动发育迟缓相关的人口统计学特征。
物理治疗师的目标是在 1 年内使用布鲁因克斯-奥塞雷茨基运动能力测试第二版(BOT-2)评估我们 CF 中心至少 50%的合格儿童(4-12 岁)。发育迟缓定义为评分低于第 18 百分位。人口统计学和临床数据包括体重指数、住院次数、基因型和合并症。基本描述性统计数据总结了患者信息。参数和非参数方法比较了感兴趣的组。线性回归评估了 BOT-2 测量值与临床特征之间的关联。
BOT-2 评估成功实施,对 69%的合格患者进行了评估。45 名(62.5%)患者的评分低于平均水平。最常见的是力量受损(22.2%),其次是平衡受损(16.7%)、跑步速度和敏捷性(15.3%)以及双侧协调(8.3%)。15.5%的患者总运动综合评分(TMC)低于平均水平。年龄增加、合并症和住院与 TMC 降低相关。
BOT-2 作为 CF 常规护理的一部分成功实施,用于筛查儿童的总体运动发育迟缓。结果表明,相当一部分 CF 患儿,尤其是患有合并症或有住院史的年龄较大的儿童,存在总体运动功能受损。这些发现支持在儿科 CF 诊所中进行常规总体运动评估和物理治疗干预的必要性。